855398-57-1

Basic information

• Product Name: 6-oxaspiro [4.5] decan-9-one
• Synonyms: 6-oxaspiro [4.5] decan-9-one;15080;EOS-61860
• CAS NO: 855398-57-1
• Molecular Formula: C9H14O2
• Molecular Weight: 154.20626
• EINECS: -0
• Mol File: 855398-57-1.mol

Chemical Properties

• Boiling Point: 100-102℃ (10 Torr)
• Appearance: /
• Density: 1.0251 g/cm3
• Refractive Index: 1.4820 (589.3 nm 20℃)
• CAS DataBase Reference: 6-oxaspiro [4.5] decan-9-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-oxaspiro [4.5] decan-9-one(855398-57-1)
• EPA Substance Registry System: 6-oxaspiro [4.5] decan-9-one(855398-57-1)

Safety Data

• Hazardous Substances Data: 855398-57-1(Hazardous Substances Data)

Usage

Uses

Used in Flavor and Fragrance Industry:
6-Oxaspiro [4.5] decan-9-one is used as a flavoring agent in food and beverages, providing a distinctive taste and aroma. It is also utilized in the production of perfumes and soaps, adding a pleasant scent to these products.
Used in Pharmaceutical Research:
6-Oxaspiro [4.5] decan-9-one exhibits potential medicinal properties, such as antimicrobial, antifungal, and insecticidal activities. These properties make it a subject of interest in pharmaceutical research for the development of new drugs and treatments.
Used in Agricultural Research:
Due to its insecticidal properties, 6-oxaspiro [4.5] decan-9-one is of interest in agricultural research for the development of eco-friendly and effective pest control methods, reducing the reliance on chemical pesticides.

Upstream product

• 75-36-5 acetyl chloride 
• 120-92-3 cyclopentanone 
• 194233-66-4 (1E)-3-{[tert-butyl(dimethyl)silyl]oxy}-N,N-dimethyl-1,3-butadien-1-amine 
• 625-33-2 3-penten-2-one 
• 855398-58-2 (+/-)-6-oxaspiro[4.5]decan-9-ol 

Downstream Products

• 1401031-20-6 2-[(9R)-9-(4-fluorophenyl)-6-oxaspiro[4.5]decan-9-yl]acetonitrile 
• 1401031-22-8 2-[(9S)-9-(4-fluorophenyl)-6-oxaspiro[4.5]decan-9-yl]acetonitrile 

Relevant articles and documents

FUSED DIHYDROINDAZOLE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN

The present invention relates to fused dihydroindazole derivatives having pharmacological activity towards the α2δ subunit, in particular the α2δ subunit, of the voltage-gated calcium channel. It also relates to compounds having dual pharmacological activ

mu-OPIOID RECEPTOR AGONIST AND PREPARATION METHOD THEREFOR AND USE THEREOF IN FIELD OF MEDICINE

Disclosed are a class of μ-opioid receptor agonists and a preparation method therefor and the use thereof in the field of medicine, belonging to the field of medicinal chemistry. The μ-opioid receptor agonists significantly increase the selectivity for a G protein signaling pathway, and not only can exhibit excellent pharmacodynamic effects, but also significantly improve safety.

Opioid receptor agonists and application thereof

The invention discloses compounds and salts thereof that can be used as opioid receptor ligands, a preparation method of the compounds, compositions containing the compounds, and a use of the compounds as [mu] opioid receptor agonists; the compounds are used for treatment of [mu] opioid receptor-mediated related diseases, such as pains and pain-related disorders.

DEUTERATED COMPOUNDS FOR TREATING PAIN

The invention provides novel chemical compounds useful for treating pain or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.

DEUTERATED COMPOUNDS FOR TREATING PAIN

The invention provides novel chemical compounds useful for treating pain or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.

PYRANOPYRIDONE INHIBITORS OF TANKYRASE

There are provided compounds of the formula or a pharmaceutically acceptable salt thereof wherein X, M, Y, R1 and R2 are as defined herein. The compounds have activity as anticancer agents.

NOVEL 4-(HETEROCYCLOALKYL)BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND ALSO IN COSMETICS

The present invention relates to novel 4- (heterocycloalkyl) benzene- 1,3-diol compounds corresponding to general formula (I) below: to the compositions containing same, to the process for the preparation thereof and to the use thereof in pharmaceutical or cosmetic compositions for use in the treatment or prevention of pigmentary disorders